Navigation Links
Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
Date:8/13/2009

or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.

(C)2009 Angiotech Pharmaceuticals, Inc. All Rights Reserved.

Quill(TM) is a trademark of Quill Medical, Inc., a wholly-owned subsidiary of Angiotech Pharmaceuticals, Inc.

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...r Advanced Micro Nano Technology Products (ACAMP) ...ONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a ...ologies like nanotechnology, biomaterials and micr... of innovative healthcare products that help promo...es of patient care, while opening new markets for ...
(Date:12/4/2009).... 4 BlueFire Ethanol Fue...used on changing the world,s transportation fuel p...-food cellulosic wastes, has been ranked number 19...Companies in Bioenergy;" the company,s second cons...rank BlueFire Ethanol among the top 20 bioenergy c...
(Date:12/3/2009)... 3 Nikon Corporation, an innovator...that it has signed a licensing agreement with Harv...e Stochastic Optical Reconstruction Microscopy (ST... Nikon will manufacture STORM enabled microscopy s..., Nikon Corporation President, Mr. Michio Kariya,...
(Date:12/3/2009)...3 VIA Pharmaceuticals, I...sed on the development of compounds for the treatm... announced that it has completed the last patient ...-2291. ,, The FDG-PET trial enrolled 52 patien... Canada including Massachusetts General Hospital, ...
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4
...(CTI),(Nasdaq: CTIC ; MTAX) management will prese...) Investor Forum on Wednesday, October 10 at 12:45...ference will also be webcast live with slides and ...ebcast can be accessed at, http://www.cticseattle....erence CTI Presentation: Wednesday...
...ding contract,research organization (CRO) providin...etic (PK)/pharmacodynamic (PD) services to the pha...ed additional MDS SCIEX API 5000(TM),and 4000(TM) ...oburn,Massachusetts. This acquisition doubles the ...city, allowing it to better serve its clientele,th...
...to Identify Pathways and Biological Proces...TY, Calif., Oct. 9 Ingenuity Systems, the,leading...ience researchers,generate insights from biologica...etabolomics(TM), a complete solution within Ingenu...nd metabolomics data in the,context of dynamic sig...
Other Biology Technology:Tandem Labs' New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England 2Ingenuity Systems Launches New Metabolomics Solution Within IPA 2
(Date:12/3/2009)...change in warmer water, according to an intriguing... some species more aggressive. , Experiments wit...reat Barrier Reef have shown for the first time th...r consistently bold, and that these individual dif...s rise. , A slight lift of just one or two degre...
(Date:12/3/2009)...vels for the past three years in the troposphere (...area near Valladolid. The results, which are the f...that the levels rose "significantly" between 2002 ...teorologists have been trying to find out about ca...ved in the troposphere over various urban and rura...
(Date:12/3/2009)...lt that occurred during the 2008-09 austral summer...es for two main climate drivers, ENSO (El Nio - So...nnular Mode), according to Dr. Marco Tedesco, Assi... The City College of New York. , Professor Ted...UNY Graduate Center, added that Antarctic snowmelt...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 5870 1China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 5870 2China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 5870 3China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 5870 4Stress induced changes in brain circuitry linked to cocaine relapse 60396 1Stress induced changes in brain circuitry linked to cocaine relapse 60396 2Stress induced changes in brain circuitry linked to cocaine relapse 60396 3Asias biggest tiger unviels promise for wild tigers 10585 1Asias biggest tiger unviels promise for wild tigers 10585 2
...Clinic Cancer Center has opened a new clinical stu...attack recurrent glioblastoma multiforme, a largel...several pending molecular medicine studies in pati...ng at better ways to treat some of the most lethal...lead researcher on the glioblastoma multiforme pro...
...esearch team found that the protein myglobin - tho...scle cells of humans and vertebrate animals - also...enabling it to survive in low oxygenated environme...diving mammals such as whales and seals and helps ... sea dives. Similarly in humans, myglobin levels i...
...rly phase study pairing an experimental targeted t...omising results in patients with advanced lung can...eported. , Pairing the targeted therapy Tarceva w...response rates in lung cancer patients by about th...fessor of hematology/oncology and lead author of t...
Other Biology News:Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 2Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 3Common carp sheds new light on surviving in extreme environments 2Combination therapy shows promising results in patients with advanced lung cancer 2Combination therapy shows promising results in patients with advanced lung cancer 3
...he FDSS6000 System is an imaging based plate reade...throughput screening which can utilize both fluore...matsu light sources and cameras in the FDSS6000 hi...oton detection technology. It is a modular, upgra...
Experion RNA StdSens Reagents and Supplies, for 10 chips from Bio-Rad
...3-(3,5-Dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofur...)-amide White solid. PROTECT FROM LIGHT. PACKAGED...zbromarone compound that acts as a selective, reve... PTP1B (IC 50 = 4 μM and 8 μM for PTP1B 403...
Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
Biology Products: